Techno Trends

This section presents the latest developments, inventions, and revolutionary technologies that change the face of healthcare.

Ibex Medical Receives CE Mark under EU’s IVDR

In accordance with the European Union's (EU) In Vitro Diagnostic Medical Devices Regulation (IVDR), Ibex Medical Analytics' Galen™ Prostate pathology diagnostics platform has obtained the CE mark. The novel platform was created to help pathologists in making a preliminary prostate biopsy diagnosis....

Guerbet Introduces a Novel Injection to Identify CNS Abnormalities

Guerbet has recently announced the official launch and initial patient dosing of Elucirem™ (gadopiclenol) injection, following its FDA approval in September 2022. This groundbreaking macrocyclic gadolinium-based contrast agent (GBCA) offers superior...

FDA Approves First-of-its-Kind Medical Arthroscope

The FDA granted 510(k) approval to Pristine Surgical for Summit, a first-of-its-kind 4K single-use surgical arthroscope intended to increase the effectiveness, reliability, and security of arthroscopic procedures. With a device that is always new and never out-of-date, Summit combines a 4K single-use surgical arthroscope with cloud-based software called Pristine Connect™ to give a high-definition...

Patent for At-Home Biometric Screening Device Issued to Reperio Health

Reperio Health's biometric home-based screening service as an innovation has been officially recognized by the U.S. Patent and Trademark Office. Reperio's flagship at-home screening kit uses FDA-cleared medical equipment to let users measure important health indicators while relaxing in their own homes. The company’s now patented Bluetooth-integrated technology allows users to get their results...

Breakthrough Device Designation for Diagnosis of Brain Tumors

A blood test called “TriNetra™-Glio” that aids in the detection of brain tumours has received "Breakthrough Device Designation" from the US Food and Drug Administration (FDA), according to a statement released by Datar Cancer Genetics. The US FDA has designated this test, the third from the company, as a breakthrough device. The first liquid biopsies to earn the Breakthrough Device Designation...

Opticyte Develops Breakthrough First Cell O2 Patient Monitor for Organ Failure

Opticyte has revolutionized patient monitoring with the introduction of the groundbreaking Cell O2 Patient Monitor. This innovative device has been granted breakthrough designation by the U.S. Food and Drug Administration (FDA)....

First-of-its-Kind Stretchable Strain Sensor Developed for Monitoring Health

The researchers at North Carolina State University have developed a stretchable strain sensor that has an unprecedented combination of sensitivity and range, allowing it to detect even minor changes in strain with a greater range of motion than previous technologies. The researchers developed new health monitoring and human-machine interaction devices to show...

Novel Radiation Treatment Developed to Treat Cancer Patients

A unique tracking radiation therapy has been developed by the University of Michigan researchers to treat cancer patients. When X-rays heat body tissues, the precise 3D imaging technology collects and amplifies minute sound waves. The radiation dose throughout the body can be mapped...

Novel Test Discovered for Multi-Cancer Detection

Burning Rock has developed OverC™, a cutting-edge method for multiple cancer screening through blood testing. The test is used to find many cancers in persons with average risk between the ages of 50 and 75, including esophagus, liver, lung, ovarian, and pancreatic cancers....

Sinaptica Therapeutics announces Phase 2 trial results for Alzheimer's Disease

According to phase 2 trial data published by Sinaptica Therapeutics, PC-rTMS, a precision-delivered noninvasive brain stimulation, delayed cognitive and functional deficits in those with mild-to-moderate dementia caused by Alzheimer's disease. 50 patients were included in a 24-week Phase II randomised, double-blind, sham-controlled...